Memews About
entertainment

🎬 Dream To You series finale wraps up

ENA's rom-com drama, "Dream to You," has concluded its run on August 18. The series featured Girl's Day's Hyeri and Hwang In Youp, airing on ENA. Nielsen Korea reported that the final episode achieved an average nationwide rating of 2.3 percent. This finale followed another show, "My Bias, My Boss," which ended its first half with a 3.626 percent rating. Viewers can now catch up on both shows on Viki.

#KDrama#ENA#SeriesFinale
business

🚨 Ex-minister, DJB CEO among 6 arrested in scam

Satyendar Jain and five others were arrested by the Anti-Corruption Branch in connection with an alleged Delhi Jal Board (DJB) scam. The arrests include former minister Satyendar Jain and former DJB CEO Udit Prakash Rai in New Delhi. The investigation stems from a vigilance complaint detailing tender manipulation for sewage treatment plant upgrades. ACB alleges Rai received bribes worth Rs 1.5 crore routed through AN Enterprises from Euroteck Environment. Further probing into the wider money trail and nexus is currently ongoing. 🚨

#DJBScam#DelhiNews#AntiCorruption
world

🀝 Trump pushing for Kim Jong Un meeting this fall

US President Donald Trump is reportedly pushing his aides for a meeting with North Korean leader Kim Jong Un this autumn. The discussion could take place during Trump's next Asia trip, possibly in November. This trip is potentially linked to the Asia-Pacific Economic Cooperation in Shenzhen, China. Trump has been privately discussing setting up this in-person conversation with Kim Jong Un. The Wall Street Journal reported this on Tuesday, citing unnamed US officials. 🀝

#TrumpKim#NorthKorea#Diplomacy
world

🀝 Trump-Kim meeting possible in November report

A potential meeting between Donald Trump and Kim Jong Un has been suggested by a recent report. The possibility of this high-profile summit involves both political figures. The timeline mentioned for this potential gathering is November of this year. This meeting could signal a significant shift in geopolitical dynamics between the US and North Korea. Further details regarding the venue and agenda are expected soon. 🀝

#Geopolitics#TrumpKim#NorthKorea
business

🎬 Suriya's film drops collections vs Jana Nayagan

'Vishwanath and Sons' earned Rs 6.35 Cr in India net on Day 5, showing an 18.6% drop from the previous day. The Suriya and Mamitha Baiju starrer continued its run across theaters in India. So far, 'Vishwanath and Sons' has collected Rs 72.30 Cr net in India, reaching a worldwide gross of Rs 128.60 Cr. Meanwhile, Thalapathy Vijay's 'Jana Nayagan' leads with a worldwide gross of Rs 323.01 Cr. The film's Tamil version is scheduled to stream on August 21. 🎬

#BoxOffice#Suriya#JanaNayagan
world

πŸ’€ Harvard settles $53M over morgue body part scandal

Harvard agreed to pay $53 million to settle lawsuits from families regarding the misuse of donated bodies. The issue involved former morgue manager Cedric Lodge, who stole and sold human remains from 2018 to 2021 at Harvard Medical School in Boston. These settlements follow Lodge's guilty plea and sentencing in 2025 for black market sales. Plaintiffs had brought civil suits alleging the university ignored the misconduct for years before the indictment. Moving forward, the school will establish an annual financial-aid scholarship starting in the 2027-2028 academic year. πŸ’€

#Harvard#MedicalScandal#Boston
entertainment

πŸ’° Emraan Hashmi hits 100 Cr solo with Awarapan 2

Emraan Hashmi's 'Awarapan 2' has crossed the β‚Ή100 crore mark in its fifth day of release. The film, starring Emraan Hashmi, is performing well in India after its August 14 release. Collections hit β‚Ή100.75 crore net in India, with a gross total of β‚Ή120 crore. Despite previous success in antagonist roles, this is his first solo lead film to reach this milestone. With a β‚Ή45 crore budget, the movie shows an impressive 122 percent return on investment.

#BollywoodHit#EmraanHashmi#BoxOffice
business

🏈 Travis Kelce launches new NIL consulting venture

Travis Kelce has launched Tekta, a new consulting service focused on NIL partnerships for college athletes. This venture is a collaboration between Kelce, Publicis Group, and 3 Arts Entertainment. Tekta aims to bridge the gap between brands and athletes by offering education on branding and finance. The service helps athletes build sustainable public profiles beyond their playing careers. This move shows Kelce is strategically planning his future, even as the Chiefs approach the 2026 season. 🏈

#NIL#TravisKelce#SportsBusiness
business

πŸ“ˆ Why Treasury Yields Are Skyrocketing

Treasury yields are rapidly increasing, signaling potential shifts in the financial landscape. This movement is being driven by various global economic factors across international markets. Specifically, yields have seen notable surges in recent weeks, hitting certain benchmarks on specific dates. This trend is largely connected to inflation concerns and Federal Reserve policy adjustments. Investors will need to monitor these changes closely to understand their impact on savings and investments moving forward. πŸ“ˆ

#Finance#Investing#Economy
tech

πŸš€ Cerebras drops new chip for faster AI chatbots

Cerebras has unveiled a brand-new server chip and an accompanying system specifically engineered to boost the speed of AI chatbots. The technology was introduced by the company at a recent industry presentation. This new hardware iteration aims to significantly enhance the processing power for large language models. It addresses the growing demand for faster and more capable AI interactions across various applications. The company expects this launch to set a new benchmark in AI infrastructure performance. πŸš€

#AI#TechNews#Cerebras
health

🧠 Can brain stimulation actually fix depression? πŸ€”

Deep Brain Stimulation (DBS) successfully treats Parkinson’s, leading researchers to test it for treatment-resistant depression (TRD) in 2017. The BROADEN study showed no significant improvement at six months between active and sham stimulation for the patients. However, later open-label phases showed much higher response rates at two years for these hard-to-treat individuals. Investigators argue the treatment didn't fail, but the study did, leading to the TRANSCEND trial. This new multicenter study started in early 2025 across 25 US sites to re-evaluate its effectiveness.

#DBS#MentalHealth#Neuroscience

j / k or ↑ ↓ to move Β· space for next

Preview of the card that will be shared